Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 95,617Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Fintepla

PharmaCompass

01

Brand Name : Fintepla

Fenfluramine

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Fintepla

arrow
Fi Europe 2024
Not Confirmed

Fenfluramine

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 124

2021 Revenue in Millions : 0

Growth (%) : New Launch in 2022

blank

02

Brand Name : Fintepla

Fenfluramine

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Fintepla

arrow
Fi Europe 2024
Not Confirmed

Fenfluramine

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 244

2022 Revenue in Millions : 125

Growth (%) : -48

blank